DME Capital Management’s Coya Therapeutics COYA Stock Holding History

DME Capital Management’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.2M	Buy	2,335,540 +309,600	+15%	+$1.45M	0.29%	40
2025 Q4	$11.8M	Buy	2,025,940 +379,500	+23%	+$2.31M	0.41%	31
2025 Q3	$9.38M	Hold	1,646,440	–	–	0.37%	25
2025 Q2	$9.47M	Hold	1,646,440	–	–	0.41%	24
2025 Q1	$10.7M	Hold	1,646,440	–	–	0.54%	22
2024 Q4	$9.43M	Buy	1,646,440 +372,414	+29%	+$2.54M	0.49%	23
2024 Q3	$8.22M	Hold	1,274,026	–	–	0.34%	27
2024 Q2	$7.72M	Hold	1,274,026	–	–	0.38%	25
2024 Q1	$12.6M	Buy	+1,274,026	New	+$9.98M	0.58%	26

Other funds holding COYA

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DME Capital Management's COYA Position: Q1 2026 in Review

DME Capital Management increased its Coya Therapeutics (COYA) stake by 15% in Q1 2026, buying an estimated $1.45M and bringing the position to 2,335,540 shares worth $9.2M. The position accounts for 0.29% of the portfolio, ranked #40.

DME Capital Management first reported a position in COYA in Q1 2024 and has held it in 9 quarters since. The position peaked at $12.6M in Q1 2024. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

DME Capital Management held 2,335,540 shares of Coya Therapeutics worth $9.2M as of Q1 2026.
DME Capital Management bought 309,600 Coya Therapeutics shares in Q1 2026, an estimated $1.45M.
Coya Therapeutics made up 0.29% of DME Capital Management's portfolio in Q1 2026, its #40 holding.
DME Capital Management first reported a position in Coya Therapeutics in Q1 2024 and has held it in 9 quarters since.
DME Capital Management's Coya Therapeutics position peaked at $12.6M in Q1 2024.
56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on DME Capital Management's 13F filing for Q1 2026, filed 15 May 2026.